Rosacea: The battle goes on

Comprehensive Therapy

Volumn 31, Issue 2, 2005, Pages 145-158

  Landow, Ken ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ADOXA; ANTIBIOTIC AGENT; AZELAIC ACID; AZITHROMYCIN; BENZAMYCIN; BENZOYL PEROXIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLARITHROMYCIN; CLENIA; CLONIDINE; COSMETIC; COTRIMOXAZOLE; DAPSONE; DOXYCYCLINE; DOXYCYCLINE HYCLATE; ERY TAB; ERYTHROMYCIN; FINACEA; IMMUNOMODULATING AGENT; KLARONA; MACROLIDE; MATRIX METALLOPROTEINASE; METROLOTION; METRONIDAZOLE; MINOCYCLINE; OVACE; PIMECROLIMUS; PLEXION; RETINOIC ACID; RETINOID; ROSAC; ROSANIL; ROSULA; SPIRONOLACTONE; SULFACET R; SULFACETAMIDE; SULFONAMIDE; SULFUR; SUNSCREEN; TACROLIMUS; TAZAROTENE; TETRACYCLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALCOHOL CONSUMPTION; ARTICLE; BACILLUS; BURNING SENSATION; DEMODEX; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DIZZINESS; EDEMA; EMOTIONAL STRESS; ERYTHEMA; EXERCISE; EYE DISEASE; FLUSHING; GENETIC PREDISPOSITION; HEART PALPITATION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; PAPULE; PATHOGENESIS; ROSACEA; SKIN CARE; STAPHYLOCOCCUS EPIDERMIDIS; SUN EXPOSURE; SWEATING; TELANGIECTASIA; WEATHER;

ANTI-INFECTIVE AGENTS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; COMPLEMENTARY THERAPIES; DERMATOLOGIC AGENTS; DRUG ADMINISTRATION ROUTES; HUMANS; ROSACEA;

EID: 26244458344     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: 10.1385/COMP:31:2:145     Document Type: Article

References (23)

1. Crawford GH, Pelle MT, James WD. Rosacea: I. etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004;51(3):327-341.
2. Cohen AF, Tiemstra JD. Diagnosis and treatment of rosacea. J Am Board of Fam Practice 2002;15(3):214-217.
3. Landow, K. Unraveling the mystery of rosacea. Postgrad Med 2002;112(6):51-58.
4. Ceilley RI. Advances in the topical treatment of acne and rosacea. J Drugs Dermatol 2004;3(5):S12-S22.
5. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002;46(4):584-587.
6. Dahl MV. Rosacea subtypes: a treatment algorithm. Cutis 2004;74(3S):21-27.
7. Kligman AM. A personal critique on the state of knowledge of rosacea. Dermatology 2004;208:191-197.
8. Rebora A. The management of rosacea. Am J Clin Dermatol 2002;3(7):489-496.
9. Pelle MT. Rosacea therapy ppdate. Adv Dermatol 2003;19:139-170.
10. Murphy G. Ultraviolet light and rosacea. Cutis 2004;74(3S):13-16.
11. Powell FC. Rosacea and the pilosebaceous follicle. Cutis 2004;74(3S):9-12.
12. Dahl MV, Ross AJ, Schlievert PM. Temperature regulates bacterial production: possible role in rosacea. J Am Acad Dermatol 2004;50(2):266-272.
13. National Rosacea Society. http://www.rosacea.org
14. Katz HI, Fraser JM. Lifestyle changes to manage sun exposure and other rosacea tripwires. Skin and Aging 2003;October(Supplement):12-16.
15. Pelle MT, Crawford GH, James WD. Rosacea: II. Therapy. J Am Acad Dermatol 2004;51(4):499-512.
16. Draelos ZD. Facial hygiene and comprehensive managemnet of rosacea. Cutis 2004;73(3):183-187.
17. Bikowski JB, Goldman MP. Rosacea: where are we now? J Drugs Dermatol 2004;3(3):251-261.
18. Bikowski JB. Subantimicrobial dose doxycycline for acne and rosacea. Skinmed 2003;2(4):234-245.
19. van Zuuren EJ, Graber MA, Hollis S, et al. Interventions for rosacea. The Cochrane Database of Systemic Reviews 2004;1:CD003262.
20. Frampton JE, Wagstaff AJ. Azelaic acid 15% gel. Am J Clin Dermatol 2004;5(1):57-64.
21. Drugstore.com. http://www.drugstore.com (accessed 12.20.04).
22. Topmedication.com. http://www.topmedication.com (accessed 12.20.04).
23. Heymann WR. Rosacea subtype-directed therapy. J Am Acad Dermatol 2004;51(1):90-92.